Company Filing History:
Years Active: 2013-2016
Title: Katrin Eppelmann: Innovator in Biochemical Synthesis
Introduction
Katrin Eppelmann is a notable inventor based in Kalamazoo, MI (US). She has made significant contributions to the field of biochemical synthesis, particularly in the production of 1,4-butanediamine. With a total of two patents to her name, her work showcases the intersection of microbiology and biotechnology.
Latest Patents
Katrin's latest patents focus on the biochemical synthesis of 1,4-butanediamine. The first patent describes a process for synthesizing 1,4-butanediamine in a microorganism that exhibits an increased level of ornithine decarboxylase activity. This increased activity is achieved through the overexpression of an ornithine decarboxylase encoding gene, which enhances translational and/or transcriptional efficiency. The process involves excreting the produced 1,4-butanediamine into a fermentation broth, from which it is subsequently recovered. The second patent also relates to the biochemical synthesis of 1,4-butanediamine, emphasizing the microorganism's increased activity of N-acetylglutamate formation alongside the enhanced ornithine decarboxylase activity.
Career Highlights
Katrin Eppelmann is currently associated with Dsm IP Assets B.V., where she continues to innovate in her field. Her work has implications for various applications in biotechnology and pharmaceuticals, contributing to advancements in sustainable production methods.
Collaborations
Katrin has collaborated with notable colleagues, including Petrus M M Nossin and Susanne M Kremer. These collaborations have further enriched her research and development efforts in biochemical synthesis.
Conclusion
Katrin Eppelmann stands out as an influential inventor in the realm of biochemical synthesis. Her patents reflect her commitment to advancing the field and her innovative approaches to solving complex challenges in biotechnology.